The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2

Roberto Costa1, Giorgio Arrigoni2, Giorgio Cozza1

  • 1Department of Biomedical Sciences and CNR Institute of Neurosciences, Viale G. Colombo, University of Padova, 35131 Padova, Italy.

Insights

Protein kinase CK2 phosphorylates lysine-specific demethylase 1 (LSD1), revealing a novel link between CK2 and epigenetic regulation. This interaction may control histone methylation through LSD1

Area of Science:

  • Biochemistry
  • Epigenetics
  • Molecular Biology

Background:

  • Protein kinase CK2 is a key regulator of the human phosphoproteome.
  • CK2 typically exists as a tetramer (α2β2) with potential isoform specialization between α and α' catalytic subunits.
  • Lysine-specific demethylase 1 (LSD1/KDM1A) is crucial for epigenetic regulation via histone demethylation.

Purpose of the Study:

  • To identify novel substrates of protein kinase CK2 using a phosphomimetic mutant.
  • To investigate the potential interaction and regulation between CK2 and LSD1.

Main Methods:

  • Proteomic analysis of human neuroblastoma SKNBE cellular extracts treated with a CK2α phosphomimetic mutant (CK2α4E).
  • Identification of LSD1 as a novel CK2 substrate and interacting partner.
  • Site-directed mutagenesis and phosphosite identification in LSD1.

Main Results:

  • LSD1 was identified as a protein specifically phosphorylated by CK2.
  • Three novel CK2 phosphorylation sites (Ser131, Ser137, Ser166) were identified in the N-terminal region of LSD1.
  • The N-terminal domain of LSD1, phosphorylated by CK2, is not essential for catalytic activity but may modulate interactions within gene regulatory complexes.

Conclusions:

  • Protein kinase CK2 directly phosphorylates LSD1, establishing a new regulatory link.
  • CK2-mediated phosphorylation of LSD1's N-terminal domain represents a novel mechanism for regulating histone methylation.
  • This finding highlights a new role for CK2 in epigenetic regulation.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K